Loneliness and symptom burden in oncology patients during the COVID-19 pandemic.
anxiety
cancer
coronavirus disease 2019 (COVID-19)
depression
loneliness
sleep disturbance
social isolation
Journal
Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
revised:
27
02
2021
received:
23
12
2020
accepted:
01
04
2021
pubmed:
28
4
2021
medline:
24
8
2021
entrez:
27
4
2021
Statut:
ppublish
Résumé
Loneliness and social isolation are significant public health problems that are being exacerbated during the coronavirus disease 2019 pandemic. Little is known about the associations between loneliness and symptom burden in oncology patients before and during the pandemic. Study purposes include determining the prevalence of loneliness in a sample of oncology patients; evaluating for differences in demographic, clinical, and symptom characteristics between lonely and nonlonely patients; and determining which demographic, clinical, and symptom characteristics were associated with membership in the lonely group. A convenience sample (n = 606) completed online surveys that evaluated the severity of loneliness, social isolation, and common symptoms (ie, anxiety, depression, fatigue, sleep disturbance, cognitive dysfunction, and pain) in oncology patients. Parametric and nonparametric tests were used to evaluate for differences in scores between the lonely and nonlonely groups. Logistic regression analysis was used to determine risk factors for membership in the loneliness group. Of the 606 patients, 53.0% were categorized in the lonely group. The lonely group reported higher levels of social isolation, as well as higher symptom severity scores for all of the symptoms evaluated. In the multivariate model, being unmarried, having higher levels of social isolation, as well as higher levels of anxiety and depressive symptoms were associated with membership in the lonely group. Study findings suggest that a significant number of oncology patients are experiencing loneliness, most likely as a result of mandate social distancing and isolation procedures. The symptom burden of these patients is extremely high and warrants clinical evaluation and interventions.
Sections du résumé
BACKGROUND
Loneliness and social isolation are significant public health problems that are being exacerbated during the coronavirus disease 2019 pandemic. Little is known about the associations between loneliness and symptom burden in oncology patients before and during the pandemic. Study purposes include determining the prevalence of loneliness in a sample of oncology patients; evaluating for differences in demographic, clinical, and symptom characteristics between lonely and nonlonely patients; and determining which demographic, clinical, and symptom characteristics were associated with membership in the lonely group.
METHODS
A convenience sample (n = 606) completed online surveys that evaluated the severity of loneliness, social isolation, and common symptoms (ie, anxiety, depression, fatigue, sleep disturbance, cognitive dysfunction, and pain) in oncology patients. Parametric and nonparametric tests were used to evaluate for differences in scores between the lonely and nonlonely groups. Logistic regression analysis was used to determine risk factors for membership in the loneliness group.
RESULTS
Of the 606 patients, 53.0% were categorized in the lonely group. The lonely group reported higher levels of social isolation, as well as higher symptom severity scores for all of the symptoms evaluated. In the multivariate model, being unmarried, having higher levels of social isolation, as well as higher levels of anxiety and depressive symptoms were associated with membership in the lonely group.
CONCLUSIONS
Study findings suggest that a significant number of oncology patients are experiencing loneliness, most likely as a result of mandate social distancing and isolation procedures. The symptom burden of these patients is extremely high and warrants clinical evaluation and interventions.
Identifiants
pubmed: 33905528
doi: 10.1002/cncr.33603
pmc: PMC9508796
mid: NIHMS1834702
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3246-3253Subventions
Organisme : NCI NIH HHS
ID : K07 CA197077
Pays : United States
Organisme : NCI NIH HHS
ID : CA197077
Pays : United States
Informations de copyright
© 2021 American Cancer Society.
Références
J Affect Disord. 2020 Oct 1;275:109-111
pubmed: 32658811
Psychiatry Res. 2020 Nov;293:113392
pubmed: 32835927
Eur J Ageing. 2009 Jun;6(2):91-100
pubmed: 19517025
Psychoneuroendocrinology. 2013 Aug;38(8):1310-7
pubmed: 23273678
Front Oncol. 2020 Jul 10;10:1357
pubmed: 32766162
Am Surg. 2020 Dec;86(12):1615-1622
pubmed: 33231496
J Pers Assess. 1996 Feb;66(1):20-40
pubmed: 8576833
Gerontologist. 2020 Sep 15;60(7):e491-e501
pubmed: 31201744
Ann Behav Med. 2021 Mar 20;55(3):203-215
pubmed: 32865550
Trends Cogn Sci. 2020 Sep;24(9):717-733
pubmed: 32561254
Cancer Nurs. 1990 Oct;13(5):293-302
pubmed: 2245416
Psychiatry Res. 2020 Aug;290:113117
pubmed: 32480121
Sleep. 1992 Dec;15(6):493-8
pubmed: 1475563
Psychiatry Res. 1991 Mar;36(3):291-8
pubmed: 2062970
Int J Cancer Suppl. 1999;12:132-7
pubmed: 10679884
Psychiatry Res. 2020 Dec;294:113551
pubmed: 33171416
Psychooncology. 2014 Dec;23(12):1356-64
pubmed: 24729533
Psychooncology. 2020 Sep;29(9):1399-1401
pubmed: 32628307
Psychol Bull. 2014 Nov;140(6):1464-504
pubmed: 25222636
Ann Behav Med. 2010 Oct;40(2):218-27
pubmed: 20652462
J Clin Nurs. 2010 Mar;19(5-6):832-9
pubmed: 20500326
Psychooncology. 2011 Feb;20(2):194-202
pubmed: 20213858
J Pain Symptom Manage. 2020 Nov;60(5):e25-e34
pubmed: 32889039
Am Psychol. 2020 Oct;75(7):897-908
pubmed: 32567879
J Racial Ethn Health Disparities. 2021 Feb;8(1):12-20
pubmed: 33230737
PLoS One. 2020 Sep 24;15(9):e0239698
pubmed: 32970764
Ann Behav Med. 2018 May 31;52(7):582-593
pubmed: 29860361
Annu Rev Psychol. 2015 Jan 3;66:733-67
pubmed: 25148851
J Clin Psychol. 1988 Mar;44(2):203-6
pubmed: 3360935
Pain. 1983 Oct;17(2):197-210
pubmed: 6646795
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Health Psychol. 2014 Sep;33(9):948-57
pubmed: 23957903
Public Health. 2017 Nov;152:157-171
pubmed: 28915435
Eur J Oncol Nurs. 2014 Oct;18(5):466-77
pubmed: 24993076
Int Psychogeriatr. 2020 Oct;32(10):1217-1220
pubmed: 32450943
Arthritis Rheum. 2003 Apr 15;49(2):156-63
pubmed: 12687505
Perspect Psychol Sci. 2015 Mar;10(2):227-37
pubmed: 25910392
Public Health. 2020 Sep;186:31-34
pubmed: 32768621
Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:472-7
pubmed: 16515647
Clin Infect Dis. 2021 Mar 1;72(5):e88-e95
pubmed: 33221832